Using functional assays including proliferation rate, ɣ-irradiation sensitivity and genomic instability, we demonstrate that BRCA1 VUS/mutations have a spectrum of phenotypes, suggesting that both deleterious mutations and VUS impart relative degrees of risk for cancer development. Here, BRCA1 is linked to cancer.